News & Updates
Filter by Specialty:
Study confirms causal link between plasma cortisol and hypertension
Individuals with higher genetically predicted plasma cortisol appear to have greater odds of hypertension, according to a Mendelian randomization analysis.
Study confirms causal link between plasma cortisol and hypertension
18 Sep 2023Does UV-B phototherapy increase the risk of skin cancer in AD patients?
Ultraviolet (UV)-B phototherapy does not appear to increase the risk of skin cancer in patients with atopic dermatitis (AD), reveals a study.
Does UV-B phototherapy increase the risk of skin cancer in AD patients?
18 Sep 2023Chloride-potassium assessment helps diagnose thiazide-associated hyponatraemia
Assessment of apparent strong ion difference (aSID), potassium, and chloride in urine is a useful tool for classifying patients with volume-depleted thiazide-associated hyponatraemia (TAH) requiring fluid substitution relative to those with syndrome of inappropriate antidiuresis (SIAD)-like presentation warranting fluid restriction, according to a recent study.
Chloride-potassium assessment helps diagnose thiazide-associated hyponatraemia
18 Sep 2023Bimekizumab safe, effective in moderate-to-severe plaque psoriasis
The high clinical response levels achieved with bimekizumab over 48 weeks persist up to week 96 in patients with moderate-to-severe plaque psoriasis, results of the BE RADIANT phase IIIb trial have shown. In addition, those on secukinumab who switched to bimekizumab have achieved similar responses at 96 weeks.
Bimekizumab safe, effective in moderate-to-severe plaque psoriasis
18 Sep 2023Sleep problems tied to risk of COVID-19 outcomes
A cross-sectional analysis has found an association between insomnia, poor sleep quality, and extremes of sleep duration and increased COVID-19 infection and hospitalization.
Sleep problems tied to risk of COVID-19 outcomes
18 Sep 2023Durvalumab plus radiotherapy shows promise in unresectable NSCLC
In the treatment of patients with programmed cell death ligand 1 (PD-L1)-positive, unresectable, and locally advanced nonsmall cell lung cancer (NSCLC), the use of durvalumab immunotherapy in combination with curative radiotherapy yields survival gains with tolerable adverse events (AEs), as shown in the results of the phase II DOLPHIN trial.
Durvalumab plus radiotherapy shows promise in unresectable NSCLC
17 Sep 2023Air pollution exposure may lead to breast cancer
Exposure to high levels of fine particulate matter (PM2.5) appears to contribute to an increased risk of oestrogen receptor (ER)-positive breast cancer, as shown in a study.